Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 14
- Markets & Stocks
Apollon Signs New Deal To Sell Assets, New Cannabis ETF Launches After Rescheduling News, & More From Stenocare
Apollon Formularies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”APOL.AQ” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its previous deal with Global Hemp Group (GHG) had now fallen through.
- Markets & Stocks
Cantourage UK Expands Medical Cannabis Access in Gibraltar, SEED Stock Jumps Nearly 30%, & More from Ananda
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] This week Cantourage UK, a subsidiary of the German-listed cannabis distribution group, signed a supply agreement which will give residents of Gibraltar greater access to medical cannabis.
- Markets & Stocks
Celadon Announces New £1.2m Supply Deal, Intercure Continues Record Run, & Chill Brands Launches Products in UK
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”CEL.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] LSE-listed Celadon Pharmaceuticals announced that it had signed a new commercial sales contract set to be worth £1.2m with an unnamed UK pharmaceutical company.
- Markets & Stocks
MGC Pharma Raises A$834k in Share Purchase Plan, & More From DanCann Pharma
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals announced the closure of its share purchase plan (SPP) this week, seeing the company successfully raise a further A$834k (£426k).
- Markets & Stocks
Pharma C Receives £30k Fine For Aquis Rule Breaches, & Akanda Pays Off Halo Loans With Stock
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has settled a loan from its most significant shareholder Halo Collective, with which it shares a CEO, by giving it shares in the company.
- Markets & Stocks
German Cannabis Stocks Jump on Passage of Draft Adult-Use Bill, More from Jazz Pharma & Ananda Developments
German Stocks Spike on Passage of Draft Law [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”SBX.DE” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Synbiotic SE (SBX) Yesterday, the German federal cabinet officially passed the draft law which would seek to implement Pillar 1 of the country’s ambitious adult-use cannabis legalisation strategy.
- Markets & Stocks
IM Cannabis Faces NASDAQ Delisting for Second Time Despite Stock Consolidation & Israeli Cannabis Stocks Jump on Reforms
IM Cannabis [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”IMCC” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] International medical cannabis operator IM Cannabis has now received its second warning from NASDAQ regarding its share price, months after pushing through a share price consolidation to remain on the exchange.
- Companies
MIRA Pharmaceuticals Launches on NASDAQ
Pre-clinical-stage pharmaceutical company MIRA Pharmaceuticals, has launched on the NASDAQ, with shares trading from 3 August 2023 under the symbol “MIRA”.
- Markets & Stocks
MGC Pharma Announces New A$2.7m Share Purchase Plan, Chill Brands Revenues Drop 87%, & Hellenic Receives EU Grant
MGC Pharmaceuticals [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”MXC.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m share purchase plan for its Australian investors, just weeks after conditionally raising a further £700,000.
- Markets & Stocks
Cantourage Expects ‘Double Digit’ Sales Increase This Year, Apollon Signs New Licence Agreement, & More from MGC Pharma
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-listed cannabis distributor Cantourage informed investors this week that it expects to see ‘double digit’ sales growth and ‘a break-even result at EBITDA level’ in 2023.
- Companies
Incannex To Relocate To US From Australia And List Shares On NASDAQ
Incannex has announced it will be relocating to Delaware, United States from Australia.
- Companies
Curaleaf Plans Toronto Stock Exchange Listing
After announcing its intentions to do so in May 2023, Curaleaf has now confirmed it aims to list subordinate voting shares on the Toronto Stock Exchange (TSX) in a bid to expand its investor base.
